Davenport & Co’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-22,000
| Closed | -$23K | – | 1010 |
|
|
2022
Q3 | $23K | Hold |
22,000
| – | – | ﹤0.01% | 962 |
|
|
2022
Q2 | $24K | Buy |
22,000
+10,000
| +83% | +$10.9K | ﹤0.01% | 960 |
|
|
2022
Q1 | $13K | Hold |
12,000
| – | – | ﹤0.01% | 1036 |
|
|
2021
Q4 | $10K | Sell |
12,000
-24,000
| -67% | -$20K | ﹤0.01% | 1047 |
|
|
2021
Q3 | $48K | Buy |
36,000
+24,000
| +200% | +$32K | ﹤0.01% | 1017 |
|
|
2021
Q2 | $23K | Hold |
12,000
| – | – | ﹤0.01% | 941 |
|
|
2021
Q1 | $54K | Buy |
+12,000
| New | +$54K | ﹤0.01% | 790 |
|
|
2019
Q4 | – | Sell |
-2,000
| Closed | -$9K | – | 749 |
|
|
2019
Q3 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 679 |
|
|
2019
Q2 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 680 |
|
|
2019
Q1 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 653 |
|
|
2018
Q4 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 630 |
|
|
2018
Q3 | $15K | Hold |
2,000
| – | – | ﹤0.01% | 677 |
|
|
2018
Q2 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 690 |
|
|
2018
Q1 | $10.8K | Buy |
+2,000
| New | +$10.8K | ﹤0.01% | 685 |
|